NDC 0024-5910 Kevzara
Sarilumab Injection, Solution Subcutaneous - View Dosage, Usage, Ingredients, Routes, UNII
Product Information
- 0024 - Sanofi-aventis U.s. Llc
- 0024-5910 - Kevzara
Product Packages
NDC Code 0024-5910-01
Package Description: 2 SYRINGE in 1 PACKAGE / 1.14 mL in 1 SYRINGE (0024-5910-00)
NDC Code 0024-5910-02
Package Description: 2 SYRINGE in 1 PACKAGE / 1.14 mL in 1 SYRINGE
Product Details
What is NDC 0024-5910?
What are the uses for Kevzara?
What are Kevzara Active Ingredients?
Which are Kevzara UNII Codes?
The UNII codes for the active ingredients in this product are:
- SARILUMAB (UNII: NU90V55F8I)
- SARILUMAB (UNII: NU90V55F8I) (Active Moiety)
Which are Kevzara Inactive Ingredients UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- ARGININE (UNII: 94ZLA3W45F)
- HISTIDINE (UNII: 4QD397987E)
- POLYSORBATE 20 (UNII: 7T1F30V5YH)
- SUCROSE (UNII: C151H8M554)
- WATER (UNII: 059QF0KO0R)
What is the NDC to RxNorm Crosswalk for Kevzara?
- RxCUI: 1923333 - sarilumab 150 MG in 1.14 mL Prefilled Syringe
- RxCUI: 1923333 - 1.14 ML sarilumab 132 MG/ML Prefilled Syringe
- RxCUI: 1923333 - sarilumab 150 MG per 1.14 ML Prefilled Syringe
- RxCUI: 1923338 - KEVZARA 150 MG in 1.14 mL Prefilled Syringe
- RxCUI: 1923338 - 1.14 ML sarilumab 132 MG/ML Prefilled Syringe [Kevzara]
Which are the Pharmacologic Classes for Kevzara?
* Please review the disclaimer below.
Patient Education
Sarilumab Injection
Sarilumab injection is used alone or with other medications to treat rheumatoid arthritis (RA: condition in which the body attacks its own joints causing pain, swelling, and loss of function). Sarilumab is usually used by people who were not helped by certain other drugs for RA or who could not take these medications. Sarilumab injection is in a class of medications called interleukin-6 (IL-6) receptor inhibitors. It works by blocking the activity of interleukin-6, a substance in the body that causes inflammation.
[Learn More]
* Please review the disclaimer below.
[1] What is the Non-Proprietary Name? - The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
[2] What is the Substance Name? - An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
[3] What kind of product is this? - Indicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
[4] What are the Administration Routes? - The translation of the route code submitted by the firm, indicating route of administration.
[5] What is the Labeler Name? - Name of Company corresponding to the labeler code segment of the Product NDC.
[6] What is the FDA Application Number? - This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
[8] What is the Marketing Category? - Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
[9] What is the Start Marketing Date? - This is the date that the labeler indicates was the start of its marketing of the drug product.
[11] What is the Listing Expiration Date? - This is the date when the listing record will expire if not updated or certified by the product labeler.
[12] What is the NDC Exclude Flag? - This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions ("Y"), or because the listing certification is expired ("E"), or because the listing data was inactivated by FDA ("I"). Values = "Y", "N", "E", or "I".